Bausch Health Companies Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Good afternoon, everybody. I'm Terence Flynn, the biopharma analyst at Goldman Sachs. This afternoon, we're very pleased to host Bausch Health Companies. Today, joining us from the company, we have Joe Papa, Chairman and CEO; Joe Gordon, who is President and Co-Head of Bausch + Lomb International; Art Shannon, who's Senior Vice President and Head of Investor Relations and Global Communications. Thank you so much all for joining us today, really appreciate the time.
Joe, maybe I'll turn it over to you first to start with some opening remarks before we go through my questions.
Sure. It's a pleasure to have a chance to talk to everybody today. We've been undergoing a transformation of Bausch Health over the past 4 years, and we put together a brand-new team, brand-new leadership team, and we've made great progress. We've now reported 9 consecutive quarters of organic growth. We've got a really strong eye health business with our Bausch + Lomb business, driven by mega trends, which
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |